antiretroviral-therapy

Documents about antiretroviral-therapy

• The incidence of, and risk factors for, liver injury in adults living with human immunodeficiency virus initiating antiretroviral therapy in a South African private sector managed care cohort#196983OpenUCT
• A Commitment Contract to Achieve Virologic Suppression in Poorly Adherent Patients with HIV/AIDS#214865BYU ScholarsArchive
• Mother to child transmission of HIV in Plateau State, Nigeria: Case-based surveillance of the HIV infected HIV-exposed infants#305610PLOS
• Perspectives on the Impacts of a Food Support Program on the Well-Being of People Living With HIV (PLHIV) and on Antiretroviral Therapy (ART) in Khomas Region, Namibia.#338753NCBI PubMed Central
• HIV&HEART Aging Study (12,5 Year Follow up)#995329ClinicalTrials.gov
• The Effectiveness of a Counselling Intervention on the Uptake of HIV Care Services Among HIV Infected Patients in Uganda#866229ClinicalTrials.gov
• Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa#879024ClinicalTrials.gov
• A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.#879635ClinicalTrials.gov
• A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients#893918ClinicalTrials.gov
• Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care#968060ClinicalTrials.gov
• Empiric tuberculosis treatment and 12-month mortality among sputum GeneXpert-negative adults living with HIV in Uganda in the era of widespread Antiretroviral therapy: A prospective cohort study#157817Unpaywall
• Effects of diabetes mellitus on virologic and immunologic outcomes of patients on first line antiretroviral therapy in a military population in South Africa#203601University of Pretoria Repository
• A Urine Tenofovir Point‐of‐Care Assay Facilitates Positive Antiretroviral Therapy Adherence Discussions Among People Living With HIV and Healthcare Providers—A Mixed‐Methods Evaluation in Cape Town, South Africa.#297536NCBI PubMed Central
• A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection#841431ClinicalTrials.gov
• Predictors of tuberculosis mortality among patients on treatment: A retrospective cohort study at a rural general hospital in Zambia#309460PLOS
• Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach#373059WHO IRIS
• Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children#873408ClinicalTrials.gov
• Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African Adults#882808ClinicalTrials.gov
• HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)#891503ClinicalTrials.gov
• Electronic Capture of Adherence Barriers for HIV Care#1030816ClinicalTrials.gov
• Quantifying excess TB prevalence among people living with HIV on ART in the universal ART era: Evidence from a TB prevalence survey in Zambia and South Africa#1040241PLOS
• Different Trends of Immune Activation Markers When Switching to Either Oral or Injectable Dual Antiretroviral Therapy Based on Integrase Inhibitors in People Living with HIV#370796HAL (France)
• Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach - 2010 version#376865WHO IRIS
• Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)#886124ClinicalTrials.gov
• Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis#888605ClinicalTrials.gov
• Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)#892854ClinicalTrials.gov
• Prevention of Mother-to-child Transmission (PMTCT) Among Women Experiencing Depression in Malawi#915213ClinicalTrials.gov
• Longitudinal Changes in Plasma Biomarkers of Immune Activation, Neuronal Inflammation and Injury in Persons With HIV Initiating ART#200795ODU Digital Commons
• A qualitative exploration of psychosocial determinants influencing viral load suppression among adolescents living with HIV: Application of social action theory#467461African Journals Online
• Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection#829648ClinicalTrials.gov
• Transition to dolutegravir-based ART in 35 low- and middle-income countries : a global survey of HIV care clinics.#361127SUNScholar
• HIV self-testing for partners of postpartum women to facilitate HIV pre-exposure prophylaxis and antiretroviral therapy uptake: a protocol to adapt and pilot an intervention via a pilot randomised controlled trial in South Africa.#280788NCBI PubMed Central
• A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.#830998ClinicalTrials.gov
• Pathways of onward HIV disclosure in relationships among young people living with vertically acquired HIV receiving antiretroviral therapy: A qualitative analysis from the BREATHER Plus trial, South Africa.#477142PubMed
• Effect of a person-centered care intervention on return and sustained reengagement after treatment interruptions from HIV care in Zambia: A post-hoc analysis of a stepped-wedged cluster randomized trial#631445PLOS
• Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral Therapy#873235ClinicalTrials.gov
• Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults#900047ClinicalTrials.gov
• ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection#905895ClinicalTrials.gov
• ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing#200838Ora Oxford University Research
• Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa#803048ClinicalTrials.gov
• A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study#810555ClinicalTrials.gov
• Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection#857957ClinicalTrials.gov
• Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV#905469ClinicalTrials.gov
• Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy#918587ClinicalTrials.gov
• Experiences of patients living with HIV and AIDS on antiretroviral therapy in Accra, Ghana#637716SUNScholar
• Data Sheet 1_Preferences of people living with HIV for treatment regimen attributes: a qualitative interview study.pdf#784688Figshare
• Data Sheet 2_Preferences of people living with HIV for treatment regimen attributes: a qualitative interview study.pdf#784689Figshare
• The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels#342900UNSWorks Repository
• Prospective Multicenter Study of the Relationship Between Virological Effectiveness and Compliance in HIV-1-infected Patients Treated With Bictegravir#879654ClinicalTrials.gov
• A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy#906256ClinicalTrials.gov